PCOS: The Most Common Hormone Disorder You’ve Probably Never Been Properly Diagnosed With

One in ten women has Polycystic Ovary Syndrome. An astounding 70% of them don’t know it.

That means right now, millions of women are walking around with a treatable hormonal condition – gaining weight they can’t explain, losing hair, breaking out like teenagers, struggling to get pregnant, and being told by their doctors that everything looks “normal.”

PCOS isn’t just about ovarian cysts. It’s not just a fertility problem. It’s a whole-body endocrine disorder that, left untreated, dramatically increases your risk of heart disease, diabetes, fatty liver, and certain cancers.

And it’s hiding in plain sight.

What PCOS Actually Is (And Isn’t)

Let’s start by clearing up the name, because it’s misleading. “Polycystic Ovary Syndrome” implies that the ovaries are full of cysts. In reality, about half of women with PCOS don’t have cystic-appearing ovaries on ultrasound. And the “cysts” that do appear aren’t true cysts – they’re small, immature follicles that never fully developed due to hormonal imbalance.

PCOS is fundamentally a disorder of hormonal signaling and metabolic dysfunction. The core problem is a disrupted feedback loop between insulin, androgens, and the hypothalamic-pituitary-ovarian axis.

Here’s the simplified version: insulin resistance drives androgen excess, androgen excess disrupts ovulation, disrupted ovulation worsens the hormonal imbalance, and the whole cycle feeds on itself.

The Many Faces of PCOS

This is where most doctors get it wrong. They were taught to look for the “classic” PCOS patient – overweight, acne, facial hair, irregular periods. And yes, that’s one way PCOS shows up. But it’s far from the only way.

The Classic Presentation:

Irregular or absent periods
Visible signs of androgen excess (hirsutism, acne, thinning hair)
Overweight, especially around the midsection
Insulin resistance
Polycystic ovaries on ultrasound

The Lean PCOS Patient:

Normal weight or even underweight
May have regular periods
Subtle androgen excess (mild acne, slight hair thinning)
Still has metabolic dysfunction hiding beneath the surface

The “Hidden” PCOS Patient:

Normal-appearing ovaries on ultrasound
Normal androgen levels on standard labs
Presents primarily with metabolic symptoms – unexplained weight gain, fatigue, brain fog
Or presents with fertility struggles as the first and only obvious sign

A significant number of women with PCOS are lean, have regular periods, or show no obvious signs of androgen excess. Some have polycystic ovaries but minimal other symptoms. This is exactly why 70% of cases go undiagnosed – doctors are looking for the textbook picture and missing the variations.

Never rule out PCOS based on body type, regular periods, or absence of visible androgen excess. The metabolic implications exist across all phenotypes.

Why PCOS Matters: It’s Not Just About Your Ovaries

Missing a PCOS diagnosis isn’t just missing a reproductive disorder. It’s missing an opportunity to prevent serious, life-threatening conditions.

Cardiovascular Disease

Heart disease is the number one killer of women. Women with PCOS face an even higher risk because they have the perfect storm of metabolic dysfunction: chronic inflammation, insulin resistance, and hormonal imbalances that accelerate cardiovascular damage. PCOS should be considered a serious cardiovascular risk factor requiring aggressive prevention strategies.

Metabolic Consequences

The metabolic disruption in PCOS creates a cascade of health risks:

Type 2 diabetes – significantly higher rates than the general population
Fatty liver disease (MASLD/NAFLD) – and here’s what’s alarming: many women develop fatty liver even when their insulin markers appear normal. This happens in both lean and overweight patients. It’s a silent threat that requires proactive screening. If you have PCOS, ask about a FibroScan.
Obesity – driven by insulin resistance, not laziness
Dyslipidemia – abnormal cholesterol and triglyceride levels

Cancer Risk

Women with untreated PCOS face a **2 to 7-fold PCOS faces a 2 to 7-fold increased risk of endometrial cancer due to irregular ovulation. Without ovulation, progesterone does not appear to balance estrogen’s effect on the uterine lining. Unopposed estrogen promotes endometrial growth month after month.

Early intervention with progesterone can dramatically reduce this risk.

Fertility

Fertility struggles often bring PCOS patients to medical attention in the first place. But the reproductive challenges go beyond conception:

Higher rates of infertility
Increased risk of miscarriage
Need for careful progesterone support during early pregnancy (if she gets pregnant while taking progesterone, she must stay on the progesterone through her first trimester)
Long-term impact on ovarian health

Mental Health

The psychological burden of PCOS is significant and underappreciated. Women often struggle with body image issues related to weight and unwanted hair growth, anxiety about fertility, depression linked to hormonal imbalances, and the frustration of managing a chronic condition that most doctors don’t fully understand.

The earlier PCOS is diagnosed and treated, the better chance we have of preventing its most serious complications. This isn’t just about managing symptoms – it’s about changing the trajectory of a woman’s long-term health.

How PCOS Is Diagnosed: The Rotterdam Criteria

PCOS is diagnosed using the Rotterdam Criteria (2003). You need at least two of the following three:

Irregular or absent ovulation (oligo- or anovulation)
Hyperandrogenism – either clinical (hirsutism, acne, androgenic hair loss) or biochemical (elevated DHEA, testosterone on labs)
Polycystic ovaries on ultrasound – 12 or more follicles in each ovary measuring 2 to 9 mm, or increased ovarian volume greater than 10 mL

But diagnosis is just the starting point. Because PCOS is a metabolic disorder, a complete workup should assess the full scope of its impact.

The Labs I Order

Hormone Panel:

Total and free testosterone (free is more sensitive for PCOS)
SHBG (sex hormone binding globulin) – often low due to insulin resistance
DHEA-S – levels above 250 to 300 mcg/dL suggest adrenal contribution
LH and FSH – a “flipped” LH:FSH ratio greater than 2:1 or 3:1 is almost pathognomonic for PCOS. Normally FSH is higher than LH. When it’s reversed, that’s a red flag.
Prolactin and TSH – to rule out conditions that mimic PCOS
17-hydroxyprogesterone – if testosterone or DHEA are elevated, this rules out late-onset congenital adrenal hyperplasia
AMH (Anti-Mullerian Hormone) – can be drawn anytime during the cycle. Values above 3.8 to 5 are highly suggestive of PCOS. Particularly useful when traditional markers are borderline.

Metabolic Panel:

Fasting insulin (not just glucose – insulin rises years before glucose goes abnormal)
Fasting glucose
HbA1c
HOMA-IR
Lipid panel
CRP (inflammation marker)

Imaging

Pelvic/transvaginal ultrasound – but remember, only about 50% will have classic cystic-appearing ovaries. Also look at endometrial thickness (normal is less than 6 mm).
DEXA scan – establishes baseline body composition. Important in both lean and overweight phenotypes.
FibroScan – screens for fatty liver disease, which is common in PCOS even when metabolic markers look normal. Don’t let normal insulin numbers discourage you from checking.

How I Treat PCOS

PCOS management isn’t one-size-fits-all. The treatment depends on the phenotype, the severity, and the patient’s goals (fertility vs. symptom management vs. long-term disease prevention). But here’s my general approach.

1. Hormonal Support

Progesterone (100 to 200 mg oral at bedtime):

This is first-line for women with irregular or absent cycles. Without regular ovulation, there’s no progesterone to protect the uterine lining. Progesterone addresses the endometrial cancer risk, helps with PMS, anxiety, and sleep, and restores the hormonal balance that PCOS disrupts.

I use body-identical micronized progesterone – not synthetic progestins – because of the better side effect profile and the additional neurosteroid benefits (progesterone converts to allopregnanolone, which calms the nervous system through GABA receptor modulation).

If her cycles are regular, she doesn’t necessarily need daily progesterone. But if she’s anovulatory or has irregular cycles, this is non-negotiable.

For more on progesterone’s sleep and mood benefits, read my post on menopause and sleep.

2. Metabolic Support (The Foundation)

Insulin resistance is the metabolic engine driving most PCOS. Addressing it is critical.

Metformin:

Start at 500 mg daily, titrate up to 1000 mg twice daily
Always supplement with B12 (metformin interferes with B12 absorption)
For women who can’t tolerate oral metformin: topical metformin (200 mg/gm in cream, 1 gm twice daily) offers comparable benefits with minimal GI side effects

Berberine/Dihydroberberine (Alternative to Metformin):

Comparable efficacy for insulin resistance
Better GI tolerance
Berberine 500 mg twice daily, or dihydroberberine 100 mg twice daily (better tolerated, 5x better absorption)

GLP-1 Receptor Agonists:

For PCOS patients struggling with significant weight, these can be game-changing
Benefits beyond weight loss: improved glycemic control, reduced androgen levels secondary to improved insulin sensitivity, reduced inflammation
I’ve written about microdosing GLP-1s for metabolic optimization at lower doses

3. Thyroid Optimization

Thyroid dysfunction in PCOS often presents with “normal” labs but reduced tissue sensitivity. If standard labs look fine but she’s symptomatic, I dig deeper.

Optimal TSH: 0.3 to 2.0 (not the standard lab range of 0.4 to 4.5)
Free T3: 3.5 to 4.3 (the active thyroid hormone that actually runs metabolism)
Consider desiccated thyroid (like NP Thyroid) starting at a low dose and titrating up

A thyroid that’s “normal” by lab standards but suboptimal by functional standards can make PCOS symptoms significantly worse – especially weight, fatigue, and hair loss.

4. Anti-Androgen Therapy

Spironolactone (100 mg daily, can increase to twice daily):

For women dealing with hirsutism, acne, or androgen-driven hair loss, spironolactone is a powerful tool. It works through multiple mechanisms:

Inhibits 5-alpha-reductase (reduces conversion of testosterone to the more potent DHT)
Blocks androgen receptors
Decreases androgen production in ovaries and adrenals
Increases SHBG, reducing free testosterone
Bonus: mild blood pressure reduction and diuretic effect

Important: it takes 6+ months for full effect on hair-related symptoms. It can be compounded into a topical for face or scalp. And it’s contraindicated in pregnancy (can cause fetal feminization), so pregnancy prevention is essential while taking it.

Monitor potassium levels periodically and blood pressure when starting.

5. Evidence-Based Supplements

These aren’t replacements for the above – they’re complementary support.

Primary:

Myo-inositol – supports ovulation and improves insulin sensitivity. This is one of the best-studied PCOS supplements.
Omega-3 fatty acids – reduces inflammation and improves insulin sensitivity
Berberine or dihydroberberine – if not using metformin (similar efficacy)
Chromium – supports insulin sensitivity

Hormonal support:

Vitex (Chaste Tree Berry) – may help regulate cycles
Saw palmetto – anti-androgenic (but contraindicated if already on spironolactone)

Supporting nutrients:

NAC (N-Acetyl Cysteine) – antioxidant support, may improve insulin sensitivity
Magnesium – involved in over 300 enzymatic reactions, most women are deficient
Zinc – supports hormonal balance
Vitamin D3 – low vitamin D is extremely common in PCOS and associated with worse metabolic outcomes
Folate – especially important if fertility is a goal

PCOS and Perimenopause: What Changes

Here’s something that rarely gets discussed: PCOS doesn’t disappear at menopause. The reproductive symptoms may change – irregular periods become no periods, fertility concerns become irrelevant – but the metabolic dysfunction persists.

Women with PCOS entering perimenopause face a unique challenge. The insulin resistance, the cardiovascular risk, the inflammation – all of that continues. And now they’re layering menopausal hormone loss on top of existing hormonal chaos.

The approach shifts but the principles remain:

Continue metabolic support (metformin or berberine, GLP-1s if needed)
Add estrogen when appropriate (these women need estrogen protection just as much as anyone)
Continue progesterone for endometrial protection, sleep, and anxiety
Monitor cardiovascular markers closely
Maintain aggressive prevention strategies

For the full breakdown of hormone therapy in menopause, read my complete guide to HRT for women.

How to Talk to Your Doctor

If you suspect you have PCOS – or if you’ve been diagnosed but feel undertreated – here’s what to bring to your appointment:

Ask for the right labs. Not just TSH and a basic metabolic panel. Request fasting insulin, free testosterone, DHEA-S, LH, FSH, AMH, and SHBG. If your doctor doesn’t know what a flipped LH:FSH ratio means, you may need a different provider.

Don’t accept “your labs are normal” as a final answer. Normal ranges are population averages, not optimal values. A fasting insulin of 15 is “normal” but metabolically terrible. A TSH of 4.0 is “normal” but you’ll feel awful.

Ask about metabolic screening. Fasting insulin, lipids, HbA1c, and consider a FibroScan for fatty liver – even if you’re lean.

Request a comprehensive treatment plan. Birth control pills alone are not a complete PCOS treatment. They mask symptoms without addressing the metabolic root cause. If your provider’s only recommendation is the pill, ask about insulin sensitizers, anti-androgens, and body-identical progesterone.

If you’re planning pregnancy, get your PCOS optimized first. Insulin resistance, untreated thyroid issues, and progesterone deficiency all affect fertility and pregnancy outcomes.

The Bottom Line

PCOS is not a cosmetic inconvenience. It’s not “just irregular periods.” It’s a systemic metabolic and hormonal disorder that affects one in ten women and goes undiagnosed in 70% of them.

The consequences of missing it are serious: heart disease, diabetes, fatty liver, endometrial cancer, infertility, depression. The consequences of treating it are dramatic: better metabolic health, restored cycles, clearer skin, healthier hair, improved fertility, and reduced long-term disease risk.

If you’re dealing with unexplained weight gain, acne that won’t quit, hair where you don’t want it (or losing it where you do), irregular cycles, or difficulty getting pregnant – ask your doctor about PCOS. Get the full workup. Don’t accept “normal” labs without digging deeper.

You deserve a diagnosis. You deserve a treatment plan that addresses the root cause, not just the symptoms. And you deserve a provider who understands that PCOS is a whole-body condition that requires whole-body thinking.

Hormone optimization is the foundation. Find a Humanaut Health clinic.

Dr. Amy Killen is a board-certified physician specializing in hormone optimization and regenerative medicine. She is the CMO and co-founder of Humanaut Health, founder of HOP, and creator of the HOT Provider Course. Follow her on Instagram and Substack for more.

References

Bozdag G, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841-2855.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25.
Teede HJ, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602-1618.
Legro RS, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565-4592.
Azziz R, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.
Unfer V, et al. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2017;6(8):647-658.
Barry JA, et al. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(5):748-758.
Tay CT, et al. Updated and expanded recommendations for the lifestyle management of PCOS. BMC Med. 2023;21:225.